发明名称 1-(ALKYL), 1-(HETEROARYL)ALKYL AND 1-((ARYL)ALKYL)-7-(PYRIMIDIN-4-YL)-IMIDAZO(1,2-A)PYRIMIDIN-5(1H)-ONE DERIVATIVES
摘要 <p>The invention relates to a imidazoÄ1,2-aÜpyrimidone derivative represented by formula (I) or a salt thereof: <CHEM> Wherein: X represents a bond, an ethenylene group, an ethynylene group, a methylene group optionally substituted; a carbonyl group, an oxygen atom, a sulfur atom, a sulfonyl group, a sulfoxide group or a nitrogen atom being optionally substituted; R1 represents a 2, 4 or 5-pyrimidinyl optionally substituted; R2 represents a C1-6 alkyl group, a C1-2 perhalogenated alkyl group, a C1-3 halogenated alkyl group, a benzyl group, a phenyl ring, a naphthyl ring, 5,6,7,8-tetrahydronaphthyl ring, a pyridyl ring, an indole ring, a pyrrole ring, a thiophene ring, a furan ring or an imidazole ring, the benzyl group and the rings being optionally substituted; and n represents 0 to 3. The invention relates also to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3 beta , such as Alzheimer disease.</p>
申请公布号 SI1480981(T1) 申请公布日期 2006.04.30
申请号 SI20030030137T 申请日期 2003.02.26
申请人 SANOFI-AVENTIS;MITSUBISHI PHARMA CORPORATION 发明人 LOCHEAD ALISTAIR;SAADY MOURAD;YAICHE PHILIPPE
分类号 A61K31/437;A61K31/519;A61P3/04;A61P3/10;A61P9/10;A61P17/14;A61P25/02;A61P25/08;A61P25/16;A61P25/18;A61P25/24;A61P25/28;A61P27/06;A61P35/00;C07D487/04 主分类号 A61K31/437
代理机构 代理人
主权项
地址